Pharmacology News

The FDA on Friday authorized a drug importation for Florida’s Agency for Health Care Administration that will enable the state to import prescription drugs from Canada, according to an agency news release.

An FDA investigation of popular weight-loss drugs has generated a storm of media attention and prompted patient questions.

Researchers linked more than 1 million deaths in Africa in 2019 to antimicrobial resistance, more than half of which were linked to just four pathogens.

New guidance was published in 2023 for STD prevention, diabetic foot infections, infective endocarditis and more.

SARS-CoV-2 rebound risk is more likely related to the individual person, rather than reinfection or resistance to treatment such as Paxlovid, according to two studies.

Findings from two cardiovascular outcome trials revealed that targeting obesity could become a major focus for treating cardiovascular disease and heart failure with preserved ejection fraction in the future, according to a speaker.

Salix Pharmaceuticals has joined forces with the U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders to declare December 5 as Opioid-Induced Constipation Awareness Day, according to a company press release.

Few adverse events following outpatient parenteral antimicrobial therapy containing cefazolin and ceftriaxone were identified using routine laboratory monitoring, leading researchers to say the practice may be “excessive.”

A cardiology-driven clinic for outpatients with heart failure appears to be an effective setting for weight loss in patients with obesity and HF, according to a research letter published in JACC: Advances.

The FDA designated a drug-device combination for periprosthetic joint infection in hip and knee replacement patients as a breakthrough therapy, which may accelerate its approval, the manufacturer said.